While the news on patients hospitalized with COVID-19 was not as hoped, the ability to positively impact outcomes when identified early is promising.
| less than a minute read
Multi-faceted approach to COVID-19: Eli Lilly Interview
Eli Lilly Chairman and CEO Dave Ricks told CNBC on Tuesday that he believes the company’s coronavirus antibody treatment will still be beneficial to Covid-19 patients, despite the recent end to a study of the drug in a hospital setting.
/Passle/5f6edd8e8cb62a0bec3e5fd2/SearchServiceImages/2023-03-16-14-34-13-558-641328e5f636ea035c4be55e.jpg)
The Biden-Harris Administration announced this week that the Department of Transportation is now accepting applications for the Charging...
/Passle/5f6edd8e8cb62a0bec3e5fd2/SearchServiceImages/2023-06-05-13-04-41-727-647ddd699778a91d5749d585.jpg)
